









Markets
/
Stocks
/
nasdaq-edap
/

Edap Tms SA

EDAP

2.030USD

+0.030+1.50%

Close 11/04, 16:00（ET）Quotes delayed by 15 min

75.91MMarket Cap

LossP/E TTM



Edap Tms SA

2.030

+0.030+1.50%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Edap Tms SA

Currency: USD Updated: 2025-11-03

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Edap Tms SA's Score

Industry at a Glance

Industry Ranking

127 / 210

Overall Ranking

278 / 4617

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 3 analysts

Hold

Current Rating

5.767

Target Price

+169.47%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Edap Tms SA Highlights

StrengthsRisks

Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 17.42% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 59.36M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 59.36M.

Overvalued

The company’s latest PE is -4.20, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 14.09M shares, decreasing 14.74% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 0.00 shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.37.

Financial Health

Currency: USD Updated: 2025-11-03

The company's current financial score is 7.24, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 13.73M, representing a year-over-year decrease of 3.29%, while its net profit experienced a year-over-year decrease of 13.07%.

Score

Industry at a Glance

Previous score

7.24

Change



Financials

6.50

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.37

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

8.71

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

6.45

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.18

Key Metrics

Free cash flow

No Data

Edap Tms SA's Company Valuation

Currency: USD Updated: 2025-11-03

The company’s current valuation score is 7.34, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -4.20, which is -2562.44% below the recent high of 103.45 and -3629.44% above the recent low of -156.68.

Score

Industry at a Glance

Previous score

7.34

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 127/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-03

The company’s current earnings forecast score is 6.67, which is lower than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Edap Tms SA is 1.80, with a high of 14.00 and a low of 1.50.

Score

Industry at a Glance

Previous score

6.67

Change

Support & Resistance

No Data

Analyst Rating

Based on 3 analysts

Hold

Current Rating

5.767

Target Price

+188.33%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Edap Tms SA

EDAP

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-03

The company’s current price momentum score is 6.34, which is lower than the Healthcare Equipment & Supplies industry's average of 6.72. Sideways: Currently, the stock price is trading between the resistance level at 2.61 and the support level at 1.57, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.54

Change

-0.2

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(3)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.069

Sell

RSI(14)

43.794

Neutral

STOCH(KDJ)(9,3,3)

42.532

Neutral

ATR(14)

0.237

Low Volatility

CCI(14)

-96.426

Neutral

Williams %R

62.667

Sell

TRIX(12,20)

-0.325

Sell

StochRSI(14)

21.568

Sell

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

2.104

Sell

MA10

2.177

Sell

MA20

2.221

Sell

MA50

2.319

Sell

MA100

1.907

Buy

MA200

2.008

Buy

Institutional Confidence

Currency: USD Updated: 2025-11-03

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.39. The latest institutional shareholding proportion is 37.69%, representing a quarter-over-quarter decrease of 9.55%. The largest institutional shareholder is CI Select Canadian Equity Fund, holding a total of 0.00 shares, representing 0.00% of shares outstanding, with 1.00% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Soleus Capital Management, L.P.

7.31M

Morgan Stanley & Co. International Plc

3.36M

-0.03%

Rock Springs Capital Management LP

1.27M

Bruce & Company, Inc.

553.65K

Apis Capital Advisors LLC

226.29K

-56.82%

UBS Financial Services, Inc.

174.67K

+354.18%

Schonfeld Strategic Advisors LLC

172.14K

+3.43%

Parkman Healthcare Partners LLC

154.83K

Cahill Financial Advisors, Inc.

134.96K

Summit Trail Advisors, LLC

102.34K

Risk Assessment

Currency: USD Updated: 2025-11-03

The company’s current risk assessment score is 2.18, which is lower than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is -0.18. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.